Exforge HCT 10-160-12.5 MG tab 30S
Ended Awarded Last action
- Contract number
- SPE2DR26F9CMR
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $1,887
Award facts
- Contract value 100% obligated
- $1,887.27 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $1,887.27 to AmerisourceBergen Drug Corp for EXFORGE HCT 10-160-12.5 mg tablets (30-count units) on January 5, 2026, with completion scheduled for January 6, 2026. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. EXFORGE HCT is a combination antihypertensive medication used in the treatment of high blood pressure, reflecting the Defense Logistics Agency's ongoing pharmaceutical supply requirements for military healthcare operations.
This delivery order represents a child contract under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. As a major pharmaceutical distributor and critical vendor for federal medical procurement, AmerisourceBergen Drug Corp supplies a comprehensive range of pharmaceuticals and medical supplies to support military and veteran healthcare systems worldwide. The company's extensive portfolio of competitively awarded federal contracts demonstrates its capability to fulfill diverse medical supply requirements across multiple therapeutic domains for defense and civilian healthcare programs.
Quick answers
Who was awarded contract SPE2DR26F9CMR?
SPE2DR26F9CMR was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 5, 2026.
How much is contract SPE2DR26F9CMR worth?
The government has obligated $1,887 on SPE2DR26F9CMR.
Is contract SPE2DR26F9CMR an order under another contract?
Yes. SPE2DR26F9CMR is a delivery order under SPE2DR25D1017, an indefinite delivery contract.
Was contract SPE2DR26F9CMR competed?
The extent of competition for SPE2DR26F9CMR was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award